Zydus gains final USFDA approval for Paliperidone Extended-Release Tablets, 1.5 mg, 3 mg, 6 mg, and… EP News Bureau Oct 10, 2024 The tablets are indicated for the acute and maintenance treatment of schizophrenia
Alembic Pharmaceuticals receives U.S. FDA approval for Paliperidone extended-release tablets EP News Bureau Sep 27, 2024 Approval covers Paliperidone tablets for the treatment of schizophrenia and schizoaffective disorder
